AU5279996A - Antibodies and their use in cancer therapy and diagnosis - Google Patents

Antibodies and their use in cancer therapy and diagnosis

Info

Publication number
AU5279996A
AU5279996A AU52799/96A AU5279996A AU5279996A AU 5279996 A AU5279996 A AU 5279996A AU 52799/96 A AU52799/96 A AU 52799/96A AU 5279996 A AU5279996 A AU 5279996A AU 5279996 A AU5279996 A AU 5279996A
Authority
AU
Australia
Prior art keywords
antibodies
diagnosis
cancer therapy
cancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52799/96A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioinvent International AB
Original Assignee
Bioinvent International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent International AB filed Critical Bioinvent International AB
Publication of AU5279996A publication Critical patent/AU5279996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A61K47/6869—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU52799/96A 1995-04-07 1996-04-01 Antibodies and their use in cancer therapy and diagnosis Abandoned AU5279996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9501302 1995-04-07
SE9501302A SE9501302D0 (en) 1995-04-07 1995-04-07 Antibodies for use in cancer therapy and diagnosis
PCT/GB1996/000783 WO1996031539A1 (en) 1995-04-07 1996-04-01 Antibodies and their use in cancer therapy and diagnosis

Publications (1)

Publication Number Publication Date
AU5279996A true AU5279996A (en) 1996-10-23

Family

ID=20397891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52799/96A Abandoned AU5279996A (en) 1995-04-07 1996-04-01 Antibodies and their use in cancer therapy and diagnosis

Country Status (3)

Country Link
AU (1) AU5279996A (en)
SE (1) SE9501302D0 (en)
WO (1) WO1996031539A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2891666T (en) 2002-10-16 2017-09-22 Purdue Pharma Lp Antibodies that bind cell-associated ca 125/o722p and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289880C (en) * 1985-12-06 1991-10-01 Jeffrey L. Winkelhake Anti-human ovarian cancer immunotoxins and methods of use thereof
JPH01211497A (en) * 1988-02-19 1989-08-24 Aichi Pref Gov Monoclonal antibody to human mucinous ovary tumor and hybridoma producing same
JP2660241B2 (en) * 1990-10-12 1997-10-08 アメリカ合衆国 Monoclonal antibody
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
JPH0723400B2 (en) * 1992-12-07 1995-03-15 愛知県 Monoclonal antibody against human mucinous ovarian tumor and method for detecting human ovarian tumor using the antibody

Also Published As

Publication number Publication date
SE9501302D0 (en) 1995-04-07
WO1996031539A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU5536196A (en) Cancer diagnosis and therapy based on mutations in tgf-beta receptors
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
AU4397297A (en) Antibody against human parathormone related peptides
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU4473596A (en) Methods of human prostate cancer diagnosis
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
AU7127196A (en) Nanoparticles in photodynamic therapy
AU2603895A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
AU7216996A (en) A paf-acetylhydrolase and use in therapy
AU4953693A (en) Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
AU7674896A (en) Adenovirus-antisense k-ras expression vectors and their application in cancer therapy
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
GB9514816D0 (en) Substances and their medical use
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL122686A0 (en) Benzylhydroxylamines their preparation and use